Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 12129303 Anti-interleukin-11 receptor subunit α (IL-11Rα) antibodies

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

David J. King0

Helen Toni Jun0

Robert A. Horlick0

Date of Patent

October 29, 2024

0

Patent Application Number

185908530

Date Filed

February 28, 2024

0

Patent Citations

US Patent 7030226 Fc fusion proteins of human erythropoietin with increased biological activities

0

US Patent 7112715 Transgenic mouse for targeted recombination mediated by modified Cre-ER

0

US Patent 7166697 V-like domain binding molecules

0

US Patent 7217797 Alteration of FcRn binding affinities or serum half-lives of antibodies by mutagenesis

0

US Patent 7244592 Ligand screening and discovery

0

US Patent 7326681 Methods for producing modified glycoproteins

0

US Patent 7425619 FcγRIIB specific antibodies and methods of use thereof

0

US Patent 7462697 Methods for antibody engineering

0

...

Patent Primary Examiner

Robert S. Landsman

0

CPC Code

0

0

0

0

0

0

Patent abstract

Provided are antibodies and antigen binding fragments thereof that bind to human interleukin-11 receptor subunit α (IL-11Rα) and related compositions, which may be used in any of a variety of therapeutic or diagnostic methods, including the treatment or diagnosis of cancers, inflammatory diseases, autoimmune diseases, and others.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 12129303 Anti-interleukin-11 receptor subunit α (IL-11Rα) antibodies

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool